JOINN Laboratories
Biotechnology and laboratory services · Beijing, Beijing
About JOINN Laboratories
JOINN Laboratories is a contract research organization (CRO) founded in 1995 and headquartered in the Beijing Economic-Technological Development Area. Listed in Shanghai and Hong Kong (603127.SH / 6127.HK), it presents itself as China's largest non-clinical safety assessment service provider, with main bases in Beijing and Suzhou totaling around 100,000 square metres of animal experiment facilities built to international standards, plus a presence in Guangzhou and the United States.
Its portfolio spans the full drug development lifecycle: drug discovery, pharmaceutical quality research and testing, non-clinical safety assessment, clinical trials and post-marketing pharmacovigilance. It also offers specialized expertise in experimental animal disease models, veterinary drug and agrochemical evaluation, medical device assessment, and bioanalysis and biomarker testing for small molecules, antibodies, and cell and gene therapies.
JOINN operates under GLP quality systems with accreditations and recognitions including CNAS/ILAC-MRA, NMPA, US FDA, OECD GLP, Korean MFDS GLP and AAALAC, allowing clients to use the data it generates in regulatory submissions in China and abroad. Its services target pharmaceutical, biotechnology, medical device, veterinary and crop-protection companies worldwide.
Its portfolio spans the full drug development lifecycle: drug discovery, pharmaceutical quality research and testing, non-clinical safety assessment, clinical trials and post-marketing pharmacovigilance. It also offers specialized expertise in experimental animal disease models, veterinary drug and agrochemical evaluation, medical device assessment, and bioanalysis and biomarker testing for small molecules, antibodies, and cell and gene therapies.
JOINN operates under GLP quality systems with accreditations and recognitions including CNAS/ILAC-MRA, NMPA, US FDA, OECD GLP, Korean MFDS GLP and AAALAC, allowing clients to use the data it generates in regulatory submissions in China and abroad. Its services target pharmaceutical, biotechnology, medical device, veterinary and crop-protection companies worldwide.